Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PDL-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07358585
What this trial is testing

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer Adenocarcinoma
Shanghai Henlius Biotech 126
Testing effectiveness (Phase 2)UnknownNCT04152889
What this trial is testing

Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Who this might be right for
Gastric Cancer Stage III
RenJi Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT07221253
What this trial is testing

Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 1,100
Early research (Phase 1)Temporarily pausedNCT05938296
What this trial is testing

OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Who this might be right for
Solid Tumor
Binhui Biopharmaceutical Co., Ltd. 29
Testing effectiveness (Phase 2)Looking for participantsNCT06857279
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma of Head and/or Neck
Shanghai Henlius Biotech 167
Early research (Phase 1)Study completedNCT03666273
What this trial is testing

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell Carcinoma
Bayer 60
Early research (Phase 1)Ended earlyNCT02706405
What this trial is testing

JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04392505
What this trial is testing

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

Who this might be right for
CancerNon Small Cell Lung CancerNon Small Cell Lung Cancer Stage III+2 more
Oslo University Hospital 100
Early research (Phase 1)Ended earlyNCT03455556
What this trial is testing

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Mesothelin PositiveStage III Non-Small Cell Lung Cancer AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7+2 more
Mayo Clinic 1
Testing effectiveness (Phase 2)Ended earlyNCT03721679
What this trial is testing

Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1

Who this might be right for
Solid Cancer
Oncovir, Inc. 7
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Large-scale testing (Phase 3)Study completedNCT03062358
What this trial is testing

Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 453
Early research (Phase 1)Ended earlyNCT03833427
What this trial is testing

Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001)

Who this might be right for
Advanced/Metastatic Solid Tumors
Merck Sharp & Dohme LLC 32
Not applicableLooking for participantsNCT06730503
What this trial is testing

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Chest Hospital 250
Large-scale testing (Phase 3)Active Not RecruitingNCT05382286
What this trial is testing

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerPD-L1 Positive
Gilead Sciences 443
Testing effectiveness (Phase 2)Active Not RecruitingNCT04753879
What this trial is testing

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableStudy completedNCT03136523
What this trial is testing

Tissue Microarrays (TMAs) Construction in Lung Cancer Samples

Who this might be right for
Lung Cancer
Kostas N.Syrigos 324
Early research (Phase 1)UnknownNCT04326296
What this trial is testing

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
LiNing 33
Not applicableActive Not RecruitingNCT07215962
What this trial is testing

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 300
Not applicableUnknownNCT05288569
What this trial is testing

IrAE Prediction of Anti-PD-1/L1 in Lung Cancer

Who this might be right for
Immune Checkpoint InhibitorsLung Cancer
Peking Union Medical College Hospital 120
Next Page